JENNIFER SCOTT: Open Payments
NPI 1952911299 · ST JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 51 payments from 17 companies in 2025. Trend: 2023 $770 · 2024 $557 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $224 |
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| PFIZER INC. | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| ABBVIE INC. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $75 |
| Lilly USA, LLC | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Amgen Inc. | 3 | $46 |
Products named: Wegovy, REXULTI, NURTEC ODT, Kerendia, BREZTRI, INJECTAFER, QULIPTA, Ozempic.
Industry payments across FL — which companies pay providers there.
